The network brings together psychiatrists, psychologists, nurses, researchers and other healthcare professionals from across Norway to share clinical experience, develop common standards and coordinate research.
NORAAD has developed a clinical protocol for intravenous ketamine treatment for treatment-resistant depression.
NORAAD contributes to the national PreKet multicentre study, funded by KLINBEFORSK.
NORAAD hosts open online meetings on the last Friday of every month from 13:00–14:00 (CET) via Microsoft Teams. Healthcare professionals interested in participating are welcome to contact the secretariat to receive a meeting invitation.
Chair: Professor Ole A. Andreassen
Secretariat: DPS Moss – Innovative Treatment and Research, Østfold Hospital
Contact: noraad@so-hf.no